i"}, {"range"™:{"length":277,"start":0},"textStyle":" anf-ts-1"}],"layout":"default- body", "role":"body", "text":"Any broad swing in voter opinion could prove difficult for
Mr. Hugin to overcome. Even with Mr. Me nearly 900,000 more registered Democrat House races that have attracted nationa
nendeza這s vulnerabilities, s than Republicans, a
New Jersey has and a number of competitive
attention.","type":"text"}, {"bannerType":"any", "identifier":" anf-banner advertisement 3","layout":"ComponentLayout-—
4","role":"banner advertisement", "type":"banner advertisement"}, {"identifier"™:" anf- heading4-1", "layout": "heading4", "role": "heading4", "text":"A once-notorious drug becomes a lucrative cancer weapon", "type":"text"}, {"identifier":" anf-body- 19","inlineTextStyles"™: [{"range":{"length":235,"start":0},"textStyle":" anf-ts-
I"}, {"range™: {"length":235,"start":0},"textStyle":" anf-ts-1"}],"layout":"default— body", "role":"body", "text":"When Mr. Hugin arrived at Celgene in June 1999, the company
was struggling to figure out how to tur which had been approved a year earlier leprosy.", "type": "text "},{"identifier"™: 20", "inlineTextStyles": [{"range": {"leng i"},{"range"™:{"Length":158, "start":0}," body", "role":"body", "text":"Thalomid wa drug that became notorious in the 1960s defects
worldwide.", thalidomid keywords=APP
W
onc EMOBIL
B®ion=written thr
ha
CLO "
profit on its treat a rare s _anf-body-
th"™:158,"start"™:0 textStyle"™:" anf- s Celgenede™s brand name for thalidomide, af
only marketed drug, kin condition caused by
}, "textStyle":" anf-ts-
oug
Thalomid,
ts-1"}], "layout": "default-
an old
ter it was traced to thousands of birth
type™:"text"}, {"additions"™: [{"URL":"https://www.nytimes.com/1997/11/28/us/ banned-is-in-demand.html?partner=applenewséad h&éasset i1d=100000006090758", "range": {"length"”
:61,"start":55},"type™:"Link"}, {"URL":"https://www.nytimes.com/1997/11/28/us/thalidomid
once-banned-is-in keywords=APPLEMOBI
:11,"start":116},"
demand. html ?partner E®ion=written thr ype": "Llink"}], "ident
21","inlineTextStyles": [{"range": {"leng 1"},{"range": {"length":358, "start":0}," body", "role" "body", "text: ! 2
new research sugges were smuggling it into the country and clubsaé€ after research sugges Kaposi sarcoma, two serious complicatio
body-22", "inlineTextStyles": [{"range": { i"},{"range":{"Length":187,"s body", "role": "body", "text":"F.D.A. of fi
sold illicitly, took willing to bring thal
the unusual step o idomide to market
=applenewséad
oughé&asset_id=100000006090758", "range": {"length" ifier":" anf-body- th":358,"start":0},"textStyle":" anf-ts- textStyle":" anf-ts-1"}],"layout":"default-
halidomide had fallen into obscurity until the 1990s, ted it could be useful for a variety of diseases. AIDS activists
selling it through black-market A4€ebuyers
ns of AIDS." "length":187,"start":0}, "texts
W
tyle™:
cials, =f seeking out drug companies t
when
ted the drug could be used for AIDS wasting syndrome and ,"type™:"text"}, {"identifier"™:
W
_anf-
ani-ts= tart":0},"textsStyle":" anf-ts-1"}],"layout":"default- alarmed that a notorious drug was being hat might be
legally.","type":"text"}, {"bannerType":"any","identifier":" anf-banner advertisement 4","layout":"ComponentLayout-—
4","role":"banner advertisement", "type":"banner advertisement"}, {"identifier"™:" anf- body-23","inlineTextStyles": [{"range"™:{"length":109,"start":0},"textStyle":" anf-ts- i"}, {"range"™:{"length":109,"start":0},"textStyle":" anf-ts-1"}],"layout":"default-
body", "role": "body", "text":"Celgene, never sold a drug, ultimately took up t challenge.", "type": "text"}, {"additions" disease/clinical-
center. html", "range": {"length":38, "star 24","inlineTextStyles": [{"range": {"leng im}, {"range"™:{"Length":251, "start":0}," body", "role":"body", "text":"In 1998, erythema nodosum leprosum, a complicati United States. In 2007, Celgene said th treat the skin condition.", "type": "text 25", "inlineTextStyles": [{"range": {"leng 1"},{"range"™: {"Llength":256, "start":0}," body", "role":"body", "text":"But leprosy was to keep the drug from harming infan up a first-of-its-kind distribution sys preapproved doctors and pharmacies.","t 26", "inlineTextStyles": [{"range": {"leng i"},{"range"™:{"Length":320,"start":0}," body", "role":"body", "text":"Celgene, me generating intens xcitement in the me clear it would not stop at treating lep
he :({"URL":"https://www.hrsa.gov/hansens-
on of leprosy, which is extremely rare in at just 100 prescriptions a year were wri "},{"identifier":" anf-body- th":256,"start":0},"textStyle":" anf-ts- texts was LS, tem that would limit prescriptions to ype": "text"}, {"identifier":" anf-body- th":320,"start":0},"textsStyle":" anf-ts- texts anwhile, had ambitious plans. dical world, rosy.
hardly the point:
Thalidomide
tyle":" anf-ts-1"}],"layout"™:"default The F.D.A.a4€™s main goal and it did so by requiring that Celgene set
then a little-known New Jersey company that had
C":113},"type"™:"Llink"}],"identifier":" anf-body- th™:251,"start":0},"textStyle":" anf-ts- textStyle"™:" anf-ts-1"}],"layout":"default-
Celgeneae™s application was approved to treat
the tten to
tyle":" anf-ts-1"}], "layout": "default-
was
and from the start the company made Celgene needed a finance executive to
HOUSE_OVERSIGHT_028417
